Endocrinology and metabolism Archives

The lived experience of adolescents with X-linked hypophosphataemia treated with burosumab at end of skeletal growth: a mixed-methods analysis

Authors: V Saraff, P Sancho, J Bacchetta, A M Boot, C Burren, AChinoy, P Dharmaraj, M A G Llorente, J D G Rodríguez, I Gueorguieva, E H Davies, W Hayes, S Komarzynski,...

Adolescents’ experience of living with X-linked hypophosphataemia (XLH): a mixed-methods analysis of those who continued and discontinued burosumab treatment after end of skeletal growth

Authors: V Saraff, P Arango-Sancho, J Bacchetta, A M Boot, C P Burren, A Chinoy, P Dharmaraj, M A G Llorente, J D G Rodríguez, I Gueorguieva, W Hayes, D Schnabel, H...

Risk of cardiovascular events, infections, and renal complications in postsurgical chronic hypoparathyroidism: A US Medicare claims retrospective analysis

Authors: W Noori, C T Sibley, V V Chirikov, K Roney, A R Smith Published: Advances in Therapy, 2025 View publication Introduction Hypoparathyroidism (HypoPT) is an endocrine disease caused by insufficient levels...

Economic burden of postsurgical chronic hypoparathyroidism: A US Medicare claims retrospective analysis

Authors: W Noori, C T Sibley, V V Chirikov, K Roney, A R Smith Published: Advances in Therapy, 2025 View publication Introduction Approximately 75% of hypoparathyroidism (HypoPT) cases result from removal of...

Healthcare utilization and costs in adults with type 2 diabetes treated with first or second-generation basal insulins in England

Authors: N Holden, O Diribe, K Palmer, A Puttanna, A Mahieu, C Nicholls, X Li Marston, N Denholm, F Saberi Hosnijeh, I Idris Published: BMJ Open Diabetes Research & Care, 2025 View...

Terlipressin versus Midodrine plus Octreotide for hepatorenal syndrome-acute kidney injury: a propensity score-matched comparison

Authors: S A Gonzalez, V V Chirikov, W-J Wang, X Huang, K Jamil, D A Simonetto Published: Clinical and Translational Gastroenterology, 2023 View publication Introduction Evidence on the comparison of treatments for...

Cost-effectiveness of terlipressin for hepatorenal syndrome: The United States hospital perspective

Authors: J A Carter, X Huang, K Jamil, S Corman, V Ektare, J Niewoehner Published: Journal of medical economics, 2023 View publication Background Hepatorenal syndrome (HRS) is characterized by severely reduced renal...

Healthcare burden and costs associated with urinary tract infections in type 2 diabetes mellitus patients: An analysis based on a large sample of 456,586 German patients

Authors: T Wilke, B Böttger, B Berg, A Groth, M Botteman, S Yu, A Fuchs, U Maywald Published: Nephron, 2016 View publication Objectives We examined the real-world treatment of urinary tract infections...

The budget impact of enzyme replacement therapy in type 1 Gaucher disease in the United States

Authors: S Farahbakhshian, T J Inocencio, G Poorman, E Wright, R R Pathak, M Bullano Published: Journal of medical economics, 2022 View publication Aim Gaucher disease (GD) is a rare autosomal recessive...

News